Semaglutide and skin rash: what's normal, what isn't, and when to act

What kinds of skin reaction does semaglutide actually cause?

Semaglutide, the active ingredient in Wegovy, acts on GLP-1 receptors to reduce appetite and slow gastric emptying. The medicine itself isn't particularly known for widespread skin effects, but two distinct patterns do appear in clinical data and in everyday prescribing.

The first, and by far the more common, is a localised injection-site reaction: a small patch of redness, mild swelling, or a fleeting itch around the point of injection. These typically settle within 24 to 48 hours. Rotating the site with each dose (moving between the abdomen, thigh, and upper arm) is the most reliable way to prevent them building up. If you store your pens in the freezer rather than the fridge, it's worth reading our guide to frozen Wegovy, which explains how improper thawing can affect the injection experience and contribute to localised irritation.

The second pattern is systemic: a generalised rash, hives, or itching that isn't confined to the injection area. This is less common and needs to be taken more seriously. The NHS medicines page for semaglutide lists rash and urticaria (hives) among the skin side effects that should be reported to a doctor or pharmacist, and notes that hypersensitivity reactions (including anaphylaxis) are listed in the prescribing information, even though severe cases are rare. If you develop a rash alongside facial or throat swelling, difficulty breathing, or a rapid drop in blood pressure, call 999 immediately.

Is a rash more likely at certain doses or stages of treatment?

There's no clear evidence that any one maintenance dose of semaglutide carries a sharply higher rash risk than another. What does tend to trigger reactions is change: the first few weeks on a new dose level are the window where the body is adjusting, and any new symptom including a skin reaction is most likely to appear during that period.

The titration schedule for Wegovy starts at 0.25 mg and steps upward roughly every four weeks, eventually reaching 2.4 mg (and, for eligible patients, up to 7.2 mg under the newer dosing options). Each upward step is a small physiological shift, and some people notice mild skin sensitivity around those transitions. If a rash appears after a dose increase, it's worth telling your prescriber at your next check-in so they can decide whether to pause the increase, manage the symptom, or investigate further.

Transfer patients (people switching to Wegovy from another treatment) sometimes ask whether the rash they had previously is likely to recur. That's a clinical question that depends heavily on what caused the original reaction, and it's exactly the kind of thing that gets reviewed during the clinical assessment before any repeat supply is approved. You can read more about what a skin rash specific to Wegovy looks like and how it differs from other reactions on the Wegovy rash page.

When should a semaglutide rash prompt urgent medical attention?

Most injection-site reactions don't need emergency care. A small red patch that comes and goes is uncomfortable, not dangerous. The threshold for seeking urgent help is when a rash is part of a wider picture.

Seek emergency medical attention if you notice swelling around the face, lips, tongue or throat alongside a rash; if breathing becomes difficult or your voice changes suddenly; or if you feel dizzy, faint or develop a rapid, spreading skin reaction. These are features of anaphylaxis, a serious but rare allergic response. Call 999 or get to A&E rather than waiting to contact your pharmacy.

For reactions that are bothersome but not immediately dangerous (widespread itching, hives that come and go, or a rash that isn't settling after a week or two) contact your prescribing team. At nume, the aftercare team is available seven days a week specifically for questions like this. Suspected side effects from any medicine can also be reported directly through the MHRA's Yellow Card scheme, which helps regulators track real-world safety signals for medicines including semaglutide.

It's also worth being aware of alternative explanations. A new washing powder, a change in diet, heat, or an unrelated skin condition can all cause rashes that coincidentally begin around the same time as a new medicine. Your prescriber can help work out whether semaglutide is actually the cause before making any changes to your treatment.

Does a rash mean semaglutide isn't suitable for you?

Not necessarily. A mild localised reaction doesn't usually mean treatment needs to stop. Simple measures (site rotation, slower injection, warming the pen first) often resolve the problem without any change to the dose or medicine.

A confirmed allergic reaction to semaglutide itself is a different matter. If testing or clinical assessment points to genuine semaglutide hypersensitivity, continuing on the same medicine isn't appropriate and your prescriber will discuss what alternatives might be suitable. Tirzepatide, the active ingredient in Mounjaro, works through a different mechanism as a dual GIP and GLP-1 receptor agonist, and some people tolerate it differently — though again, that's a clinical decision, not something to self-navigate.

If you're weighing up your options or wondering whether a skin reaction you've had should change your treatment plan, a clinical review is the right starting point. The weight-loss treatments page explains the consultation process and what a prescriber looks at when assessing suitability. The question of whether a rash changes anything is one our prescribers are used to working through, it's a clinical call, made by a real person, not a checklist. There's more detail on distinguishing skin reactions from other semaglutide side effects, including what different rash types typically look like and when to act, on our page covering whether Wegovy can cause a skin rash, and you can find a closer look at how frequently this side effect actually occurs, along with guidance on what to watch for, on our page exploring whether Wegovy can cause a rash.